(Q30840887)

English

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

multiple drug resistance

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

Alfredo Ponce-de-Leon

object named as

Alfredo Ponce-de-Leon

9

0 references

Tjip S van der Werf

object named as

Tjip S Van der Werf

14

0 references

16

object named as

Dick Menzies

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

author name string

Mayara L Bastos

1

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Hamidah Hussain

2

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Karin Weyer

3

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Lourdes Garcia-Garcia

4

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Vaira Leimane

5

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Chi Chiu Leung

6

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Masahiro Narita

7

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Jose M Penã

8

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Kwonjune J Seung

10

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Karen Shean

11

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

José Sifuentes-Osornio

12

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Martie Van der Walt

13

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Wing Wai Yew

15

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Collaborative Group for Meta-analysis of Individual Patient Data in MDR-TB

17

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

language of work or name

0 references

publication date

5 August 2014

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

59

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

10

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1364-1374

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Delamanid for multidrug-resistant pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Extensively drug-resistant tuberculosis in california, 1993-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Randomized trials to optimize treatment of multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Public-private collaboration for multidrug-resistant tuberculosis control in New York City.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Drug-susceptibility testing in tuberculosis: methods and reliability of results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Results of a 12-month regimen for drug-resistant pulmonary tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

21 June 2018

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

A multilevel model framework for meta-analysis of clinical trials with binary outcomes.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Multidrug resistance among persons with tuberculosis in California, 1994-2003.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Clinical and operational value of the extensively drug-resistant tuberculosis definition

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU619

21 January 2018

Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

25 November 2018

Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

25 November 2018

Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

25 November 2018

Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

25 November 2018

Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296130

25 November 2018

Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multilevel models for meta-analysis, and their application to absolute risk differences

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is second-line anti-tuberculosis drug susceptibility testing reliable?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An intervention programme for the management of multidrug-resistant tuberculosis in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/25097082

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/CID/CIU619

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30840887&oldid=1968737510"